India's benchmark indexes are likely to open little changed on Tuesday, after logging their best day in more than four years ...

Indian pharma stocks fell 1.6% on Monday, bucking broader market gains, after U.S. President Trump said he would cut drug ...

(Reuters) -Indian pharmaceutical stocks shed 1.3% on Monday, even as the broader markets rose, after U.S. President Donald ...

Pharma stocks rise amid market drop due to limited impact from US pricing order. Discover more on what fuels this trend.

Pharma stocks lit up Dalal Street on Tuesday as President Donald Trumps remarks on drug pricing sent mixed signals to global ...

A day after logging their biggest single-day gain in over four years, Indian benchmarks cooled off on Tuesday as traders ...

Indian pharmaceutical shares dropped up to 7% following US President Donald Trump's pledge to significantly lower US drug ...

Analysts said that the US President Trump’s latest executive order on drug price control could indirectly discourage Indian ...

Indian Pharma stocks were on a strong uptrend today, with the Nifty Pharma index rising by 1.19% in intraday trade.

Pharma stocks faced a downturn after US President Donald Trump revealed plans to slash drug prices. Sun Pharmaceuticals and ...

US President Trump's move to cut drug prices by 30–80% may severely impact Indian pharma exports and profitability, ...

By linking US drug prices to those paid in similar economies, order could alter how pharmaceutical companies price their ...